For diabetics, a finger poke is like a
photograph — the blood sample it takes only illustrates what’s
happening in a single second. For a complete view of blood sugar levels,
you’d need something more like a video stream. Fortunately, that’s
exactly what a continuous glucose monitor (CGM) offers.
Because of this, McMaster Children’s
Hospital will integrate CGM with insulin pumps during a one-year trial
aimed at managing Type 1 diabetes in children.
“This study is taking the first step
in that integration by using a pump that automatically suspends delivery
of insulin when the blood sugar levels are dangerously low,” says Dr.
Karen McAssey, Pediatric Endocrinologist at McMaster Children’s
Combining the devices has given
greater control to adults with Type 1 diabetes — the hope is that this
study will determine the best time to start kids on similar management.
According to McAssey, giving the pump the ability to respond to the CGM
will create a consistent, automatic assessment/delivery system that
could prevent life-threatening seizures or comas and make a difference
in their daily lives.
The study, set to follow 128 patients (aged five to 18 years) at five sites across Ontario, launches Tuesday, May 22.
People interested in participating can contact study co-ordinator Tamara Caceres at 905-521-2100, ext. 76055 or email firstname.lastname@example.org.